Cargando…

Antibody biomarker for de novo Parkinson disease: attempted validation

Parkinson disease (PD) is a progressive neurodegenerative disease with motor symptoms that result from degeneration of midbrain dopaminergic neurons. Biomarker research seeks to identify the disease during the pre-symptomatic phase, which is a time when therapeutic intervention will be most helpful....

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Na, Simanski, Scott, Islam, Kazi, Hynan, Linda S., Kodadek, Thomas, German, Dwight C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125321/ https://www.ncbi.nlm.nih.gov/pubmed/30211310 http://dx.doi.org/10.1038/s41531-018-0064-2

Ejemplares similares

Blood biomarker for Parkinson disease: peptoids
por: Yazdani, Umar, et al.
Publicado: (2016)

Discovery of Native Autoantigens via Antigen Surrogate Technology: Application to Type 1 Diabetes
por: Doran, Todd M., et al.
Publicado: (2014)

Utility of Redundant Combinatorial Libraries in Distinguishing High and Low Quality Screening Hits
por: Doran, Todd M., et al.
Publicado: (2014)

A Search for Blood Biomarkers for Autism: Peptoids
por: Zaman, Sayed, et al.
Publicado: (2016)

Roadblocks for integration of novel biomarker concepts into clinical routine: the peptoid approach
por: Vanderstichele, Hugo, et al.
Publicado: (2014)

Advances in blood-based protein biomarkers for Alzheimer's disease
por: Clark, Lorraine Fuhrmann, et al.
Publicado: (2013)

Parkinson's Disease: Unanticipated Sequela of an Attempted Suicide
por: Grossman, Jonathan T, et al.
Publicado: (2020)

Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease
por: Zeighami, Yashar, et al.
Publicado: (2019)

Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson’s disease patients for the identification and validation of biomarkers for Parkinson’s disease subtypes, progression and pathophysiology
por: Boertien, Jeffrey M., et al.
Publicado: (2020)

The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease
por: Halsband, Claire, et al.
Publicado: (2018)

Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson’s disease
por: Sung, Mi Sun, et al.
Publicado: (2019)

Effects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s Disease
por: Lee, Young-gun, et al.
Publicado: (2022)

Response Monitoring in De Novo Patients with Parkinson's Disease
por: Willemssen, Rita, et al.
Publicado: (2009)

The Role of the Subthalamic Nucleus in Sequential Working Memory in De Novo Parkinson's Disease
por: Ye, Zheng, et al.
Publicado: (2020)

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
por: Caspell-Garcia, Chelsea, et al.
Publicado: (2017)

Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomers
por: Gearhart, Tricia L., et al.
Publicado: (2016)

The Sequence Effect in De Novo Parkinson’s Disease
por: Kang, Suk Yun, et al.
Publicado: (2011)

Oculomotor impairments in de novo Parkinson’s disease
por: Zhou, Meng-Xi, et al.
Publicado: (2022)

Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder
por: Singh, Sarika, et al.
Publicado: (2017)

Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease
por: Santiago, Jose A., et al.
Publicado: (2016)

Peripheral Neuropathy in de novo Patients with Parkinson's Disease
por: Lee, Jae Jung, et al.
Publicado: (2020)

Plasma α‐synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson’s disease
por: Ren, Jingru, et al.
Publicado: (2022)

First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites
por: Elanga Ndille, Emmanuel, et al.
Publicado: (2012)

Targeted Discovery and Validation of Plasma Biomarkers of Parkinson’s Disease
por: Pan, Catherine, et al.
Publicado: (2014)

Network structure of brain atrophy in de novo Parkinson's disease
por: Zeighami, Yashar, et al.
Publicado: (2015)

Sex Differences in Brain and Cognition in de novo Parkinson's Disease
por: Oltra, Javier, et al.
Publicado: (2022)

Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort
por: Di Lazzaro, Giulia, et al.
Publicado: (2021)

Parkinson’s Disease Blood Test for Primary Care
por: O’Bryant, Sid E., et al.
Publicado: (2022)

De novo pathway-based biomarker identification
por: Alcaraz, Nicolas, et al.
Publicado: (2017)

Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson’s disease and de novo dementia with Lewy bodies
por: Oka, Hisayoshi, et al.
Publicado: (2020)

De novo Sequencing of Novel Mycoviruses From Fusarium sambucinum: An Attempt on Direct RNA Sequencing of Viral dsRNAs
por: Mizutani, Yukiyoshi, et al.
Publicado: (2021)

The hydrophobic patch of ubiquitin is required to protect transactivator–promoter complexes from destabilization by the proteasomal ATPases
por: Archer, Chase T., et al.
Publicado: (2010)

Direct Comparison of Linear and Macrocyclic Compound Libraries as a Source of Protein Ligands
por: Gao, Yu, et al.
Publicado: (2015)

Global analysis of gene expression mediated by OX(1) orexin receptor signaling in a hypothalamic cell line
por: Koesema, Eric, et al.
Publicado: (2017)

Orthostatic Hypotension and Cognitive Impairment in De Novo Patients with Parkinson’s Disease
por: Bae, Hyo-Jin, et al.
Publicado: (2014)

Cognition, Olfaction and Uric Acid in Early de novo Parkinson’s Disease
por: Lee, Hwa Reung, et al.
Publicado: (2018)

Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
por: Boertien, Jeffrey M., et al.
Publicado: (2022)

Speech and gait abnormalities in motor subtypes of de‐novo Parkinson's disease
por: Rusz, Jan, et al.
Publicado: (2023)

An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease
por: Biagioni, Francesca, et al.
Publicado: (2021)

Low serum lipid levels as predictors of future suicide attempt in Parkinson's disease
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0upmvc4jmom8olajs9kj7cfj0t